Pallavi Singh Chauhan, Meerambika Mishra, Bhupendra Koul, Mayank Sharma and Dhananjay Yadav* Pages 594 - 601 ( 8 )
Sleep disorders have been shown to increase the risk of dementia. This particular aspect may affect the cognition of the patient, leading to behavioral disorders and depression. In early symptomatic Alzheimer’s Disease (AD), Default Mode Network (DMN) disruption occurs and progresses along with the course of the disease. This review mainly focuses on the leading causes of AD along with management of conditions like insomnia, obstructive sleep apnea, night-time sleep duration, Circadian Rhythm Disorder (CRD), neuroendocrine alternation, and impaired sleep to prevent the use of drugs that can cause complications, especially falls or additional cognitive deficits. Moreover, this study highlights the identification of molecular mechanisms like the effect of impaired sleep on amyloid β (Aβ) and tau dynamics, impaired proteostasis, along with appropriate measures to treat few contributing factors that lead to insomnia in AD or Mild Cognitive Impairment (MCI).
Alzheimer’s disease, dementia, impaired sleep, insomnia, cognitive impairment, sleep disturbance.
Amity Institute of Biotechnology, Amity University, Madhya Pradesh, Gwalior 474005, Department of Infectious Diseases and Immunology, College of Veterinary Medicine, University of Florida, P.O. Box 110880, Gainesville, FL, School of Bioengineering and Biosciences, Lovely Professional University, Phagwara 144411, Punjab, Department of Electronics and Communication, ITM University, Gwalior 474001, Department of Medical Biotechnology, Yeungnam University, Gyeongsan 38541